clinical trials using digital twins for cardiac rehab

In recent years, the emergence of digital twin technology has revolutionized various fields, especially in healthcare. Digital twins, virtual replicas of physical entities, allow f...

Digital twin technology in healthcare is an emerging approach that creates virtual representations of patients and disease-specific conditions, with t…

World Health Organization (WHO) estimates 17.9 million deaths globally every year due to Cardiovascular Disease or CVD, which includes an array of disorders of the heart and blood ...

Digital twins (DTs) can transform randomized clinical trials by improving ethical standards, including safety, informed consent, equity, and data privacy. They also enhance trial e...

Digital twins have progressed, but ethical, regulatory and data-driven hurdles must still be overcome for the industry to see their widespread use.

Cardiovascular disease remains the world’s leading cause of mortality, yet everyday care still relies on episodic, symptom-driven interventions that detect ischemia, arrhythmias, a...

In this episode of the Applied Clinical Trials Brief, we spotlight a recent video interview in which Jon Walsh, founder and chief scientific officer of Unlearn.AI, shared how digit...

Digital twins offer a promising approach to advancing healthcare by providing precise, noninvasive monitoring and early detection of diseases. In heart failure (HF), a leading caus...

Digital Twin technology revolutionizes modern medicine with the creation of real-time virtual models of patients, organs, and healthcare systems; all …

Digital Twin (DT) technology has emerged as a transformative force in healthcare, offering unprecedented opportunities for personalized medicine, treatment o...


Related Content From The Pandipedia